E

Elevance Health

Sells health insurance and pharmacy benefits

Engineer Lead

Full-TimeUpdated on 10/23/2026Deadline 10/30/26
No salary listed
Senior
Bachelor's, Bachelor of Arts (BA)
Atlanta, GA, USA
HybridIn-office 1–2 days per week; must be within reasonable commuting distance from an office.
Software EngineeringBackend Engineering
Company Historically Provides H1B Sponsorship

About the job

Requirements
  • A Bachelor of Arts or Bachelor of Science degree in Information Technology, Computer Science, or a related field, and at least 7 years of related experience; alternatively, an equivalent combination of education and experience.
  • Multi-platform and multi-dimensional experience, including experience with business and technical applications.
  • Experience mentoring others and providing troubleshooting support is strongly preferred.
  • Experience with multiple databases and/or multiple programming languages is strongly preferred.
  • Experience with Kubernetes at platform scale, handling tens of millions of requests per day, is strongly preferred.
  • Expertise in at least one of Python, Go, or TypeScript is strongly preferred.
  • Experience working with traditional machine learning or generative AI workflows and systems in a regulated environment is strongly preferred.
Responsibilities
  • Maintain active relationships with customers to determine business requirements and lead requirements-gathering meetings.
  • Lead requirements-gathering meetings and review designs with the business.
  • Lead efforts with the web and marketing teams to increase the presence of web products.
  • Implement improvements in stability, performance, and scalability across major business-critical systems, as needed.
  • Implement processes to reduce barriers and roadblocks in projects, services, and processes to improve efficiency, as needed.
  • Own the change request process and coordinate with other teams as necessary; develop and own the final list of enhancements.
  • Develop and define application scope and objectives and supervise the preparation of technical and/or functional specifications for program development.
  • Perform technical design reviews and code reviews.
  • Ensure unit testing is completed and meets test-plan requirements, system testing is completed, and the system is implemented according to plan.
  • Deliver application technology solutions and data information planning efforts.
  • Coordinate and manage on-call support and own the system monitoring process.
  • Own the technical development environment and work on the Enterprise team.
  • Lead multiple or large projects and facilitate large-group JAD sessions for requirements and modeling across several disciplines.
  • Lead vendor evaluation and analysis.
Desired Qualifications
  • Experience mentoring others and providing troubleshooting support.
  • Experience with multiple databases and/or multiple programming languages.
  • Experience with Kubernetes at platform scale, handling tens of millions of requests per day.
  • Expertise in at least one of Python, Go, or TypeScript.
  • Experience working with traditional machine learning or generative AI workflows and systems in a regulated environment.

About the company

Elevance Health is one of the largest U.S. health insurers, covering people through employers, individual plans, Medicare and Medicaid. It is the Blue Cross Blue Shield licensee in 14 states, where it sells plans under the Anthem name, and it runs government plans under the Wellpoint name in other markets. Its Carelon division runs the CarelonRx pharmacy benefit manager and sells behavioral health, care management and other services to its own plans and outside clients. Elevance earns most of its revenue from premiums paid by employers, members and government programs, plus fees for Carelon services. The company is headquartered in Indianapolis, Indiana.

Company Size

10,001+

Company Stage

IPO

Headquarters

Indianapolis, Indiana

Founded

1944

Get referred to Elevance Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Equity has room to recover: in July 2026 Elevance raised its outlook to at least $27 adjusted earnings per share.
  • ACA plans are a growth engine: Elevance had about 1 million marketplace members by June 2026, beating its 900,000 outlook.
  • Leaders target a rebound: in July 2026 management set a goal of at least 12% earnings growth for 2027.

What critics are saying

  • Medicaid exits cost jobs: Elevance filed notice in September 2026 to cut 216 Louisiana staff, after 85 in D.C.
  • Medicaid loses money: Elevance expects a 1.75% operating loss there in 2026 and plans more state exits.
  • Regulators flagged data shortcuts in February 2026: Elevance sent Medicare diagnosis fixes on USB drives, a $935 million liability.

What makes Elevance Health unique

  • Elevance owns the Blue brand in 14 states: it is the Anthem Blue Cross licensee from California to New York.
  • Elevance keeps drug spending in-house: its CarelonRx pharmacy benefit manager handles prescriptions for its own plan members.
  • Carelon sells care beyond insurance: Carelon Services revenue rose 7.2% to $8.0 billion in the quarter ending June 2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Medical, dental, & vision insurance
  • 401(k) + match
  • Paid holidays
  • Paid Time Off
  • Incentive bonus programs
  • Stock purchase plan
  • Life insurance
  • Wellness Programs
  • Financial education resources
  • Adoption & Surrogacy Assistance
  • Dependent-care Flexible Spending Account (DCFSA)
  • Parental Leave

Company News

Yahoo Finance
Oct 27th, 2026
Elevance, CVS and Humana: three US health insurers worth $265B suited to higher rates

A Simply Wall St screen flags three large US health insurers as well placed if interest rates stay higher for longer: Elevance Health, CVS Health, and Humana. The screen favours quality value companies with solid balance sheets and dependable cash flow. Elevance Health has a market value of about $95.1 billion. Its Health Benefits unit brings in about $170.4 billion of revenue, and Carelon's CarelonRx and Carelon Services add about $45.1 billion and $30.1 billion. CVS Health is valued at about $119.5 billion, with Health Services revenue of about $200.5 billion. It took a $1.1 billion charge tied to Medicare and Individual Exchange businesses and a $1.2 billion restructuring charge for store closures. Humana, valued at about $50.7 billion, draws about $139.7 billion from insurance and $24.7 billion from CenterWell. Regulators are sharpening their focus on its risk adjustment data and prior authorization standards.

MedicalDaily Inc.
Oct 23rd, 2026
Elevance earns $1.4 billion quarterly profit as membership falls by 487,000 and insurer calls 2026 the Medicaid trough.

Elevance earns $1.4 billion quarterly profit as membership falls by 487,000 and insurer calls 2026 the Medicaid trough. Published Oct 23, 2026 9:45 AM EDT By Cole Mercer Elevance Health, the parent of Anthem and Wellpoint plans, reported a $1.4 billion third-quarter profit on October 21 while covering 487,000 fewer people than a year earlier. Executives told investors that 2026 marks the low point for the company's Medicaid profit margins and that they expect improvement next year. Elevance's medical membership stood at about 44.9 million on September 30, according to Fierce Healthcare. Quarterly profit rose from $1.2 billion a year earlier, though profit for the first nine months of the year fell to $4.6 billion from $5.1 billion. Elevance raised its full-year outlook to adjusted earnings of at least $29 per share. For the roughly 8.2 million people Elevance covers through Medicaid in more than a dozen states, the outlook is more than investor language. The company is leaving some Medicaid markets, tightening spending on certain services and preparing for federal work requirements that begin in January. Each of these can affect whether families keep their plan, their doctors and their therapies. Profits rise while enrollment shrinks. The "trough" description comes from Elevance itself. Chief Financial Officer Mark Kaye said the company's progress reinforces its view that "2026 is the trough for Medicaid margins," with improvement expected in 2027. Elevance had projected its Medicaid business would run at an operating margin of about negative 1.75% this year. It now expects slightly better results after several states raised their payment rates in July, according to Healthcare Dive's earnings coverage. CEO Gail Boudreaux told investors that "Medicaid is moving from stabilization to improvement." Insurers say their Medicaid troubles began after pandemic-era coverage protections ended and states rechecked eligibility. Healthier members tended to leave the program, while those who stayed needed more care, and state payment rates lagged behind those higher costs. Elevance's third-quarter earnings release reported a benefit expense ratio, the share of premium revenue spent on medical care, of 90.6%, an improvement from a year earlier. Other lines of business helped. Elevance now expects to end 2026 with at least 1.2 million individual ACA marketplace members, up from a prior forecast of 1 million. Its Medicare Advantage plans also became more profitable after the insurer trimmed underperforming plans and shifted toward HMOs with narrower networks, Healthcare Dive reported. The other side of that ledger is coverage. Each member an insurer drops or loses must find another plan, reapply for Medicaid, or go uninsured. For a family, that can mean new doctors, new approval requirements and paperwork deadlines. Families in Medicaid face a shifting map. Elevance exited the Washington, D.C., Medicaid market this summer and has signaled more exits through the end of 2027 in states where it does not see a path to sustainable results. In Louisiana, the Healthy Blue Medicaid contract, a joint venture with Blue Cross and Blue Shield of Louisiana, ends December 31, and Elevance is cutting 216 jobs tied to the wind-down, Becker's Payer Issues reported. More than 290,000 Healthy Blue members must choose another plan during a special enrollment period that runs from October 15 through November 16, according to Becker's. Elevance has also moved to control spending on behavioral health care, including applied behavior analysis therapy for children with autism, which Healthcare Dive described as a major driver of spending. Parents whose children rely on that therapy may face added reviews or authorization steps and should keep treatment records and provider letters on hand. A larger change arrives in January. Federal law now requires many adults in the Medicaid expansion group to show work, school, or community service hours to keep coverage. In an interim final rule issued in June, federal regulators projected about 2.3 million people would be disenrolled in fiscal year 2027 because of the requirement, according to a HealthInsurance.org summary of the federal interim final rule. Iowa begins enforcing it December 1, ahead of the national start. Felicia Norwood, Elevance's chief health benefits officer, said the company is "encouraged by what we're seeing in our 2027 rates." She also said the effect of work requirements will vary state by state and that Elevance will wait to see how states carry them out. Pressure spreads to hospital bills. The company's cost-control push also reaches hospitals. Elevance announced on September 29 that it will require hospitals to report the physical location where care was delivered on claims and will adjust payment for some off-campus services across its commercial, Medicare Advantage and Medicaid plans, with changes phased in through the end of 2027. Felix Segre, director of revenue integrity at Houston-based Memorial Hermann Health System, told Becker's Hospital Review that the policy "could mean added billing checks, more rework and payment delays when location details do not match payer records." Patients are not the target of the rule, but billing disputes between insurers and hospitals can surface as delayed claims or confusing statements. Several questions remain open. Elevance has not named which additional Medicaid states it may exit, and states are still finalizing how they will carry out work requirements. Federal enrollment data showing the real-world effect will lag by months. Medicaid members can take practical steps now. Update your address and phone number with your state Medicaid office so renewal and work-requirement notices reach you. Read any letter about plan changes promptly, ask whether your doctors are in the new network, and request continuity-of-care protections if you are in the middle of treatment. Marketplace open enrollment begins November 1, but adults who lose Medicaid because they did not meet work requirements are generally barred from marketplace premium tax credits under the 2025 law, so those families should check their options carefully. Key questions answered. What did Elevance report? A third-quarter profit of $1.4 billion, up from $1.2 billion a year earlier, and about 44.9 million medical members, 487,000 fewer than a year ago. What does "trough year" mean? It is the company's own description. Elevance executives say 2026 is the low point for Medicaid profit margins and expect improvement in 2027. Which Medicaid members could be affected? Members in markets Elevance exits, including Washington, D.C., and Louisiana's Healthy Blue plan, plus expansion adults subject to new work requirements. When do Medicaid work requirements begin? Most states must begin enforcing them in January 2027. Iowa starts December 1, 2026. What should Medicaid members do now? Update contact details with the state Medicaid office, read all notices quickly, confirm doctors are in network, and ask about continuity of care if in treatment. Will this change hospital bills? Elevance's new billing rules for off-campus care target hospitals, not patients, but disputes can delay claims. Patients who receive confusing bills should call their insurer and the hospital billing office. Published by Medicaldaily.com

Yahoo Finance
Oct 23rd, 2026
Elevance Health shares rise 2.6% to $445 as Q3 revenue hits $51B and guidance is raised

Elevance Health shares rose 2.6% to about $445 after the insurer reported third-quarter 2026 results and raised its full-year outlook. It now expects adjusted earnings per share of at least $29 for 2026, and at least 12% adjusted EPS growth in 2027. Revenue reached $51.43 billion, up from $50.71 billion a year earlier. Net income rose to $1.37 billion from $1.19 billion, and basic EPS climbed to $6.30 from $5.32. Profitability is thinner, though. The trailing 12-month net margin fell to 2.5% from 2.8%. The benefit expense ratio was 90.6%. CarelonRx posted about 10.8% operating gains and a 5.3% margin. Medical membership had fallen to 44.9 million by the second quarter.

Yahoo Finance
Oct 22nd, 2026
Elevance Health raises 2026 outlook as Q3 EPS beats by 48.9% on $50.4B revenue

Elevance Health beat Wall Street expectations in the third quarter of 2026 and raised its full-year outlook. Revenue was flat year on year at $50.44 billion, against analyst estimates of $48.93 billion. Adjusted earnings per share were $6.99, 48.9% above the $4.69 consensus. The insurer raised its full-year adjusted EPS guidance to $29 at the midpoint, up 7.4%. Management credited Medicaid rate increases, cost controls, and growth at its Carelon health services unit. It expects Medicaid margins to begin recovering in 2027 and aims to expand Carelon's business beyond its own health plans. Customers totalled 44.88 million, down from 44.95 million in the previous quarter. Shares trade at $436.75, giving a market value of $94.15 billion.

DistilInfo
Oct 22nd, 2026
Four insurers exit Medicaid as margins turn negative.

Four insurers exit Medicaid as margins turn negative. At least four insurers are leaving Medicaid managed care contracts this year and next, a retreat driven by margins that have turned negative as enrollment falls and the remaining members prove costlier to cover. The Medicaid underwriting margin dropped from nearly 3 percent during the public health emergency to negative 1 percent in 2024, below the industry's 1 to 2 percent target, according to a Robert Wood Johnson Foundation analysis. The exits matter for states, which must move members to new plans mid-contract, and for providers, who lose and gain payer relationships as assignments shift. They also raise a question for state Medicaid agencies: whether current rates can sustain a competitive bidding field. Which insurers are exiting Medicaid managed care. According to published reports compiling state and company disclosures: * Centene is leaving two programs. Its Ohana Health Plan exits Hawaii's QUEST managed care program Dec. 31, and Ambetter leaves the Arkansas Health and Opportunity for Me expansion program the same day, reportedly affecting about 70,000 members. * Healthy Blue, a collaboration between Blue Cross and Blue Shield of Louisiana and Elevance Health, ends its Louisiana Medicaid managed care participation Dec. 31, reportedly affecting about 290,000 members. * Elevance Health's Wellpoint exited the District of Columbia managed care program Aug. 1 and is cutting 85 jobs in Washington during the transition. * Baylor Scott & White Health Plan left the Texas Medicaid managed care market in August and cut 321 jobs as it also prepares to exit the individual marketplace. More departures appear likely. On a July earnings call, Elevance executives said they expected additional Medicaid exits over the next 12 to 18 months without naming the markets. Why Medicaid margins collapsed. The core problem is a mismatch between who left the program and how states set rates. Medicaid enrollment peaked at roughly 94.6 million in mid-2023 during pandemic continuous-eligibility protections. After redeterminations resumed, about 25 million people were disenrolled, more than half for administrative or procedural reasons. Enrollment stood at 73.2 million in June 2026, down 5.1 million, or 6 percent, from a year earlier, based on CMS monthly data compiled by KFF. People who left tended to be healthier, which raised the average acuity of those remaining while state capitation rates lagged behind. Medical loss ratios reflect the squeeze. They averaged 90.9 percent in 2024 and rose to 91.2 percent in an analyzed subgroup of states, with Idaho and Minnesota exceeding 100 percent in 2025 and Colorado and Maryland above 95 percent. What insurers are telling investors. Elevance has maintained a full-year 2026 Medicaid operating margin forecast of about negative 1.75 percent, describing 2026 as the trough year. Reporting second-quarter results in July, the company said rate updates came in stronger than expected while cost pressure concentrated in behavioral health, applied behavior analysis therapy, specialty pharmacy, outpatient surgery and emergency department use. Notably, executives attributed that pressure to higher utilization among continuing members rather than a fresh jump in acuity. Chief Financial Officer Mark Kaye said the company was "not seeing a new stepwise acuity reset." Health Benefits Officer Felicia Norwood said Medicaid remains "a very core part of our portfolio," a signal that selective exits are not a wholesale withdrawal. Elevance's second-quarter net income fell 16.6 percent to $1.4 billion, though it raised full-year guidance to adjusted earnings of at least $27 per share. Policy changes ahead. Further enrollment decline looks likely. A national Medicaid work requirement for the expansion population takes effect in 2027 under the budget reconciliation law, and more frequent redeterminations will add administrative churn. Urban Institute analysis cited by the Robert Wood Johnson Foundation projects that 4.6 million to 5.2 million adults in the expansion population could lose coverage. If departures again skew toward healthier members, the acuity problem compounds rather than resolves. What it means for states and providers. State Medicaid agencies face a narrower bidding field precisely as they absorb federal cuts, which weakens their leverage in rate negotiations. Agencies that hold rates down may find fewer bidders at the next procurement. For providers, each exit means renegotiating with whichever plans absorb the members, and transitions carry documented risks of coverage gaps and care disruption. For insurers remaining in Medicaid managed care, the opportunity is market share in states where competitors have left, assuming rates eventually catch up to the acuity they are now covering.